EyeBiotech Ltd.
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-34
RECRUITING3
READOUTS ≤12 MONTHS1
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| BRUNELLO NCT06571045 |
P2/3 | Active, not recruiting | Diabetic Macular Edema (DME) | 984 | 2026-07-14 (-18 mo) |
| BAROLO NCT06957080 |
P2/3 | Active, not recruiting | Diabetic Macular Edema (DME) | 1054 | 2027-01-11 (-18 mo) |
| Super Tuscan NCT07205887 |
P2 | Recruiting | Neovascular Age-Related Macular Degeneration (NVAMD); Branch Retinal Vein Occlusion (BRVO) | 160 | 2028-06-30 |
| MALBEC NCT07440225 |
P2/3 | Recruiting | Macular Degeneration; Age-Related Macular Degeneration | 960 | 2028-06-30 |
| TORRONTES NCT07496567 |
P2/3 | Recruiting | Macular Degeneration; Age-Related Macular Degeneration | 960 | 2028-07-31 |